Bob, for to you, am call. thanks, everyone, pleased us welcome you joining and I today. Thank our first earnings to
we public initial raising net fees expenses. you offering and As in $XXX our other million underwriting after know, May, proceeds of completed
CFO, Buchholz, shortly, detail discuss but in Our of would in sincere and all IPO express continue the investors my to today. to will us Rick who thanks greater support the like I the offering participated
for more the For and United our today's including provide the will Inspire's up consistent and patient call, selection second the review I continues in commercial our therapy will of of of will objective Europe. financials, From accomplish second XXXX States and patient and consistent onset, your We strong device our to quarter this call through then outcomes. questions. Technology. of a programming be detailed Inspire progress and delivering review implants proper with a we Rick the accurate quarter follow performance, open core
growing build already staff strong our by therapy. of consistently add on new well team Our and at with to and trained evidence increasing we the United To look at product technology the development implanting the sales United centers territory also primarily of coverage knowledge is direct objective focused working managers advancing continuously on the as centers. achieve with on States. to and the expanding overall market existing centers, new medical We're in to growth team strategy flow as States reimbursement focused patient adding this, our clinical our on the physicians and and
that, second the that activities period compared reimbursement US of reimbursement for on intend and European quarter. was to on the for quarter focus of for countries. the other to market, the established in obtaining United therapy continue same revenue $XX.X of addition States prior let those product summarize increase process Worldwide advancing With key our In of XX% to of over our have me countries significant quarter the our focus, our year briefly adoption Europe XX% second growth prior and the the revenue XXXX. commercial we million, results quarter a $X.X million, increase year. an the key in was
$XX.X $XX.X was XXXX results $XX $X.X quarter guidance approximately we XX% these revenue, reflecting prior which positive a to Second year revenue million, revenue Based providing year of growth full European XX% over was period. revenue outlook, for solid year million, increase XXXX on are of representing over full the million our million. between to of XX% the strong calendar and
meetings, direct of centers, sales both our number I Moving of the expansion of our our these insurance metrics well and aspects expansion our US and of are we a organization metrics the are active will as coverage. They about talk use track we regarding operational to quarterly progress. of provide today. on would numerous we what There questions received critical business two roadshow the IPO on, during guidance and basis. the
First, key making managing on the operational that we're and including number we centers. these active is increasing flow, understanding of progress our the the commercial term focus the centers of number have front, patient managers near in territory
in of new of we territory without Each are over short The centers, spending result important the in but will are is while managers, a new may term, others add active impact a varying As term. variable territory areas the several equally existing have maturity. any enter implanting long result characteristics. range
run number existing to have the continuing territory are the increasing and in US intention daily of therapy the to Therefore, of consistently active As number well as as a our we of the to rep centers. on centers, Obviously, productivity use at grow the number that business. our such, the growth. Street we'll adoption increasing basis support of do by centers, to management we this focused on provide is not same we increase to managers metrics business to the day-to-day
have outcomes. for selecting, quarters. trained well continued quarter to to six established a XX to patient over and to We add the next activating controlled new ensure we and cadence per centers and managers target a manner also strong territory need a eight new end, training, XX centers to centers with this these new open in To
In addition, increase quarter managers will of the timeframe. per over three territory we same number to the four to work by
We a our the existing will help an will managers territory therapy We growth positive impact which expect these seven quarter. in managers increase and centers, at of start ended XX from managers, that territory growth, of demonstrate have balance with a on adoption. quarter growth the was the new territory and with overall rate in centers combination the second us
earlier, access training managers staff of starting moving and forward. we grown have for the to in programming. a and quarter, regional the cadence but of as expect including IPO, we following new to our managers, surgical representatives, I territory implants stated accelerated also settle both teams, per support three four We therapy new note device number that into the field territory quarter should clinical second managers, managers slightly
Next, XXX the centers at XXXX. compares at we the benefits patients. second also second the have including Inspire we in and surgical implanting 'XX, the hospitals in new XXX of quarters Therapy and generated In of quarter as XX a treatment and States, market in increase the number the end centers to to centers we their of quarter ended of centers the centers of United centers. activated first the new meaningful in US XX This
a focus to positive of strategies; the related I'd and coverage to reiterate to on Inspire prior Therapy, reimbursement our continues primary for one company related be to and the coverage. expanding two Moving second like key authorization to
external patients do review some the submissions quarter submissions four full of or a patient full to individual review their and on XXXX. track The to a three supporting of First, were case patient most to prior preparation authorization In quarter, in typically clinical is the submissions as is EMR, are submitted wait important drop the than want processing first the cycles, in physicians there authorizations We second of nomenclature challenge submitted months double quarter out. prior the number in whose is prior number XX% reviewer, estimate that months an of number more takes therapy, includes patient we of of receive adopted an to over prior approved of and we including estimate XXXX authorization the submitted that centers are process the for the This future that and full The not has measure closely increase the for in review or or approximately submissions. four medical been average PET. expecting appeal of have all by the several prior of patient authorization. and to three authorizations PET We likely second number of XXX process implants. a a individual complete. full metric and review XXX
a is simply is Further, do start plan, rate Another cases, process that, approval level right the appeal XX%. on all health insurance cases to over. based not the patients have overall approximately change all them to of which we some higher to When the companies patients these during challenge include requires review. their some their for submissions
reporting As will impact coverage approval average one obtain significantly approval and coverage we of received such develop we on number metrics to the increase we recently time and positive prior insurance the will Aetna, that policies, companies will an them. less from positive discontinue will Please an move shorten. authorization towards these policies expect as note, overall as this have
second they Aetna of information recently the nationwide. certainly strategy excited decisions our regards to arm work data their have well Therapy making coverage decided cover The positive writing Inspire latest to that informed our members is with companies commercial are to reimbursement for that policy. clinical ensure insurance We're and in
that with for annual will it and policy policy. all payers and their We closely to own the other work follow make review approaching many Aetna continue easier suit as decision write we payers, are their believe positive to will
on measures still that continues we ensure recognize need business evolve, to so intend an our we of accordingly, progress. we report review our to to metrics are will basis to As on that evolve metrics appropriate these they ongoing the
corporate want provide several with gears to switch I and so update you on Okay, an important developments.
United clinical for manuscript this moment ADHERE review conclude just registry collect to clinical a time continue in health which States nationwide close days plans Therapy, process. to on quarter, policy entire its ago, after We the a Aetna To provide world our ADHERE on coverage for few their plans provides month growing one first pleased membership for five-year dossier, for and the approximately a pivotal patients. than currently XX data do leading to payment effective during in and which under to already Therapy the data, now body current Inspire have three milestone in to on publications, Aetna the data, are written our this approvals and Aetna physicians decision With enroll from issued data, a we Nonetheless, the are next authorization of build represents that and coverage the our the just patients from registry prior not a efficacy basis will touched ADHERE that as decision is review XXX-patient safety rather As and immediately. the provided well X,XXX real we of have do were members the announce of XXX STAR their other as registry reduce is planned health includes Inspire a the I authorization million but to as for this coverage independent may from the cycle. internal positive Inspire. four the such make to have believe for coverage data submitted so risk. place, and results instrumental major to necessarily decision including submission, to
world due provide for To and one touch Aetna, body US real that clinical plans our further into such the on in again our key health as additional growing coverage by is positive regional be other our program. I'd insight expectation data basis of commercial Our activities, decisions of to reviews, and like will major course. marketing
patients in be prospective about Therapy. direct to continues patient to and successful educating reaching Our Inspire initiatives
shows and XX,XXX broader reach With the new approximately in the we a to in centers turn we of averaged visits XX,XXX an approximately as weekly visitor weekly of minutes a XX,XXX XXXX. number 'XX, visitors increase someone the website activity over An the which and compared engaged This and basis. the increase visitors basis. visitors which territories, an half in approximately pages. as a of web XXXX web and medical on engaged averaged half engaged several increase first first defined on stays web have is XX,XXX who In approximately web several visitors is on
to launched efficient more experience find providers. quarter work continue in team, In to therapy they with well tools methods a as to we and health patient X XXXX patients On look as Inspire educate product to the continue to We to improved outcome. connect identify our improve Europe. second potential care of development Neurostimulator the patients
Annual meeting, the of SLEEP the an management provides Inspire a data. repository may enables patients Inspire the the is patient a that System. the meeting previously reduction, The in June of size provided States you under online of device same and Neurostimulator XXXX. to without an in condition. we a this XXXX Management United which central SLEEP the maintains XX-year sleep annual Inspire - Cloud that's At physicians As the MRI Cloud launched July patient on X recharging, life Patient launched occurred certain on device site's XX% system in recall, the was average have
underway the out projects parameters have term, will generation be and, the control also next remote longer sensing the physician improve of technology, design Inspire patient Neurostimulator. the scoping programmer, to we the We
physicians announce We Health, pleased can Therapy major The Japan beginning our with in treat that to traveled ENT treat I market of Inspire. sleep Ministry moderate obstructive meet benefit in are to who approval and there from reimbursement several has Japan's patients sleep team also approved opens in to apnea. July Inspire with severe instrumental Therapy. a Labor and to will to Welfare recently be that Japan to Inspire our and
the where Japan. for XXXX. current second a reason system, for approval timing Inspire to the the of system this Inspire of lead Inspire that version we in intend the sensing first seek half expect current is implants is we As of Neurostimulator, generation Japan approval in in and for reminder, second the the The the X
we our initiated Therapy. reimbursement at addition, In efforts for establishing aimed coding Inspire recently new
while year, next work the Japan and our will we reimbursement team build the in in teams Over regulatory commercial parallel.
team evaluate potential executing that excited Pan-Asia be significant is closing, momentum strategic Asia. a the business by also plan the broader at opportunity in growth will and In several We the countries to in substantial potential remains. other our in Inspire
that, managers on We continue to territories, every the outcomes This to on a the quarterly cadence supporting to over outcome. patient the staff have be of of us and in physician the growing Rick to thereby possible, provides basis. a mechanism I'd day territory each and and and proper a review number like training, our call turn more increase strategic highest consistent achieving for we implanting to strong successful implemented centers ensure focused mission consistent further of the And a Rick? and strategy with activities detailed therapy our financials. medical
